Correlations between BMP-4 gene expression, heterotopic Ossification and function after uncemented total hip replacement;Związek między ekspresją genu dla BMP-4 a kostnieniem pozaszkieletowym oraz ich wpływ na funkcję stawu biodrowego po całkowitej bezcementowej alloplastyce

Ortopedia Traumatologia Rehabilitacja

Volumn 15, Issue 2, 2013, Pages 117-124

  Kwapisz, Adam ^a   Kozłowski, Piotr ^a   Szemraj, Janusz ^b   Synder, Marek ^a   Sibiński, Marcin ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Division of Medical Biochemistry   (Poland)

Author keywords

Bone morphogenetic protein; Function; Heterotopic ossification; PCR; Total hip arthroplasty

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

ADULT; FEMALE; FOLLOW UP; GENETICS; HETEROTOPIC OSSIFICATION; HIP PROSTHESIS; HUMAN; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BONE MORPHOGENETIC PROTEIN 4; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS, HIP; POSTOPERATIVE COMPLICATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84877682168     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: 10.5604/15093492.1045951     Document Type: Article

References (30)

1. Ackerman LV. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 1958; 40: 279
2. Chauveau C, Devedjian JC, Blary MC, Delecourt C, Hardouin P, Jeanfils J, Broux O. Gene expression in human osteoblastic cells from normal and heterotopic ossification. Exp Mol Pathol 2004; 76: 37
3. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kölbl O. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Jo-int Surg Br 1997; 79: 596
4. Déjerine Y, Ceiller. A Para ostéoarhtopathies des paraplégiques par lesion médullaire. Rev Neurol 1919; 32: 399
5. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006; 65: 1289
6. van der Heide HJ, Spruit M, Slappendel R, Klooster N, van Limbeek J. Prophylaxis for heterotopic ossification after prima-ry total hip arthroplasty. A cohort study between indomethacin and meloxicam. Acta Orthop Belg 2004; 70: 240
7. Hannallah D, Peng H, Young B, Usas A, Gearhart B, Huard J. Retroviral delivery of Noggin inhibits the formation of hetero-topic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 2004; 86: 80
8. Saudan M, Saudan P, Perneger T, Riand N, Keller A, Hoffmeyer P. Celecoxib versus ibuprofen in the prevention of heteroto-pic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br 2007; 89: 155
9. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973; 55: 1629
10. Pohl F, Seufert J, Tauscher A, Lehmann H, Springorum HW, Flentje M, Koelbl O. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty. Strahlenther Onkol 2005; 181: 529
11. Grzegorzewski A, Kozłowski P, Synder M. Heterotopic ossification as a complication of total hip replacement. Chir Narza-dow Ruchu Ortop Pol 2000; 65: 255.
12. Persson PE, Sodemann B, Nilsson OS. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop Scand 1998; 69: 111
13. Sell S, Willms R, Jany R, Esenwein S, Gaissmaier C, Martini F, Bruhn G, Burkhardsmaier F, Bamberg M, Küsswetter W. The suppression of heterotopic ossifications: radiation versus NSAID therapy-a prospective study. J Arthroplasty 1998; 13: 854
14. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg 2004; 12: 116
15. Kocic M, Lazovic M, Mitkovic M, Djokic B. Clinical significance of the heterotopic ossification after total hip arthroplasty. Orthopedics 2010; 33: 16
16. Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM. In vivo so-matic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 2003; 85: 2332
17. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893
18. Kotajima S, Kishimoto KN, Watanuki M, Hatori M, Kokubun S. Gene expression analysis of ectopic bone formation induced by electroporatic gene transfer of BMP4. Ups J Med Sci 2006; 111: 231
19. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS. Overexpression of an osteogenic morpho-gen in fibrodysplasia ossificans progressiva. N Engl J Med 1996; 335: 555
20. Jiang XQ, Chen JG, Gittens S, Chen CJ, Zhang XL, Zhang ZY. The ectopic study of tissue-engineered bone with hBMP-4 ge-ne modified bone marrow stromal cells in rabbits. Chin Med J (Engl) 2005; 118: 281
21. Feldman G, Li M, Martin S, Urbanek M, Urtizberea JA, Fardeau M, LeMerrer M, Connor JM, Triffitt J, Smith R, Muenke M, Kaplan FS, Shore EM. Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am J Hum Genet 2000 Jan; 66: 128
22. Kaplan FS, Shore EM. Progressive osseous heteroplasia. J Bone Miner Res 2000; 15: 2084
23. Harris WH. Traumatic arthritis of thr hip after dislocation and acetabular fractured: treatment by mold arthroplasty. An end--result study using a new method of result evaluation. J Bone Joint Surg Am 1969; 51: 737
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156
25. Elmstedt E, Lindholm TS, Nilsson OS, Törnkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Ac-ta Orthop Scand 1985; 56: 25
26. Kan L, Lounev VY, Pignolo RJ, Duan L, Liu Y, Stock SR, McGuire TL, Lu B, Gerard NP, Shore EM, Kaplan FS, Kessler JA. Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem 2011; 112: 2759
27. Kim SY, Choi HY, Myung KB, Choi YW. The expression of molecular mediators in the idiopathic cutaneous calcification and ossification. J Cutan Pathol 2008; 35: 826
28. Jackson WM, Aragon AB, Onodera J, Koehler SM, Ji Y, Bulken-Hoover JD, Vogler JA, Tuan RS, Nesti LJ. Cytokine expres-sion in muscle following traumatic injury. J Orthop Res 2011; 29: 1613
29. Koczy B, Stołtny T, Swiderski M, Pyda M, Pajak J, Spindel J, Wawrzynek W, Miszczyk L, Kasperczyk S, Widuchowski J. Heterotopic ossification in patients with hip osteoarthritis below forty years old after total hip replacement. Ortop Trauma-tol Rehabil 2009; 11: 458.
30. Zarzycka M, Reszke J, Windorbska W, Ziółkowska E. Radiotherapy in the prevention of heterotopic ossification after arthro-plasty. Ortop Traumatol Rehabil 2002; 4: 230.